Meningococcemia

Search with Google Search with Bing
Information
Disease name
Meningococcemia
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00539032 Completed Phase 3 Immunology and Safety of Menactra® in Children in Saudi Arabia September 2007 February 2009
NCT00700713 Completed Phase 2 Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26 June 2008 March 2009
NCT00771849 Completed Phase 2 Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children August 2003 May 2004
NCT00772070 Completed Phase 2 Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine March 2003 May 2004
NCT01133834 Completed Correlation Between Cytokines and the Severity of Meningococcal Disease March 2003 June 2011
NCT00777257 Completed Phase 4 Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine April 2005 September 2007
NCT00777790 Completed Phase 2 Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents February 2004 April 2005
NCT00772629 Terminated Phase 2 Antibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy Adults January 2004 April 2004